PEOPLE ON THE MOVE
Abivax
Abivax, a biotech specialising in anti-viral drugs and therapeutic vaccines, has appointed Jean-Marc Steens chief medical officer.
Steens joins Abivax with almost three decades of biopharmaceutical experience, especially related to viral disease. For the last two years, he has worked as a consultant to pharma companies, including Novartis, and sits on steering committees within the WHO and the US National Institutes of Health.
Before his consultancy work, Steens was VP and international medical director of ViiV Healthcare, with responsibility for Eastern Europe, Asia and Latin America. He has also held positions at Sandoz and Glaxo.